Contact

Jason.Sakamoto@uth.tmc.edu
Tel:  713-500-2466
Fax: 713-500-2462

Education:

• Biographical Sketch

Summary:

Dr. Sakamoto is a native Northern Californian recently transplanted to Houston, Texas.  In 1997, he graduated with a B.S. in Material Science Engineering from The University of California at Berkeley under the mentorship of Dr. Mauro Ferrari.  Dr. Sakamoto entered the medical device industry after graduation and was employed as coronary and peripheral stent manufacturing and process engineer at the Guidant Corporation in Santa Clara, California. In 2000, Dr. Sakamoto rejoined Dr. Ferrari and pursued his doctorate in Biomedical Engineering at The Ohio State University.  During his graduate school career, Dr. Sakamoto investigated innovative computational approaches for the molecular analysis of breast cancer through the utilization of targeted nano-particle ultrasonic contrast agents. Also during this time, Dr. Sakamoto founded a biotech startup upon his research and funded this entrepreneurial venture by entering and winning numerous business plan competitions across the nation that amounted to over $135,000 in cash and services. 

Upon completion of his Ph.D., Dr. Sakamoto remained as a post-doctoral researcher in Dr. Ferrari’s research group and also worked as a business development consultant for several biotech start-ups. Furthermore, Dr. Sakamoto served as the acting President of the International Society of BioMEMS and Biomedical Nanotechnology (ISBBN).  In 2006, Dr. Sakamoto merged the ISBBN with the American Academy of Nanomedicine where he now serves on the Board of Directors. 

Currently, Dr. Sakamoto is positioned as the Chief Operating Officer of the Alliance for NanoHealth (ANH), a consortium of research institutions of the Texas Medical Center and Greater Houston Region dedicated to the commercialization of nanotechnology aimed to solve some of medicines most challenging problems.